Article Information
History
- June 9, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- J. Schniering1,
- M. Maciukiewicz1,
- H. S. Gabrys2,
- M. Brunner1,
- C. Blüthgen3,
- C. Meier1,
- S. Braga-Lagache4,
- A. Uldry4,
- M. Heller4,
- O. Distler1,
- M. Guckenberger2,
- H. Fretheim5,
- A. Hoffmann-Vold5,
- C. T. Nakas6,7,
- T. Frauenfelder3,
- S. Tanadini-Lang2 and
- B. Maurer1,*
- 1Center of Experimental Rheumatology, Department of Rheumatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland
- 2Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Zurich, Switzerland
- 3Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland
- 4Proteomics and Mass Spectrometry Core Facility, Department for BioMedical Research (DBMR), University of Bern, Bern, Switzerland
- 5Department of Rheumatology, Oslo University Hospital, and Institute of Clinical Medicine, University of Oslo, Oslo, Norway
- 6Laboratory of Biometry, University of Thessaly, Volos, Greece
- 7University Institute of Clinical Chemistry, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
- ↵*Materials & Correspondence For data and material requests please contact the corresponding author (britta.maurer{at}usz.ch).
Posted June 09, 2020.
Resolving phenotypic and prognostic differences in interstitial lung disease related to systemic sclerosis by computed tomography-based radiomics
